Why Can Proper Randomization Still Produce Baseline Imbalance Between Groups?

If Participants Were Randomized Correctly, Why Are Their Baseline Characteristics Different?

You have completed randomization for a controlled trial. The allocation sequence was generated correctly, assignments were concealed, and participants were enrolled according to the protocol. Yet the baseline table shows that one group has a higher average age, greater disease severity, or stronger prior academic achievement than the other.

Does this mean randomization failed? Should the groups have been identical if the procedure was genuinely random?

The confusion arises from a common misunderstanding of what randomization guarantees. Random assignment protects against systematic allocation based on participant characteristics, but it does not force every characteristic to be distributed equally in a particular trial.

Understanding this distinction matters because an inappropriate response to baseline imbalance can introduce more methodological problems than the original chance difference.

Randomization Produces Balance in Expectation, Not in Every Realized Sample

Understanding Baseline Imbalance Without Misinterpreting Randomization

What Does Randomization Actually Guarantee?

Randomization assigns participants or other eligible units to treatment conditions according to a prespecified chance mechanism.

When the sequence is generated correctly, allocation is concealed, and enrollment is not manipulated, treatment assignment is independent of baseline characteristics under that mechanism.

This provides the foundation for estimating causal effects without systematic baseline confounding arising from treatment selection.

However, randomization does not guarantee that every realized allocation contains identical distributions of age, prior achievement, disease severity, or other characteristics.

The distinction is between properties of the randomization procedure and characteristics of the particular allocation it produces.

Randomization supports comparability across the distribution of possible assignments. The actual trial observes only one of those assignments.

What Does Balance in Expectation Mean?

Balance in expectation means that, across repeated hypothetical applications of the randomization procedure to the same eligible participants, baseline differences between treatment groups average to zero under an appropriate symmetric allocation design.

It does not mean that the observed difference in a single trial must equal zero.

Suppose a trial randomly assigns 100 students to two feedback conditions. Their baseline writing scores vary considerably.

Across all possible allocations under a balanced randomization mechanism, neither treatment is systematically favored to receive students with higher scores.

Nevertheless, the particular allocation used in the trial might place more high-achieving students in one condition.

This is compatible with valid randomization. A realized difference is not itself evidence that assignment was manipulated.

Why Is Baseline Imbalance More Noticeable in Small Trials?

With fewer randomized units, individual characteristics can exert a larger influence on the observed group distributions.

Consider a trial involving 20 students, including four with exceptionally high prior achievement. Under simple randomization, those four students might not be distributed equally between the treatment groups.

If three enter one group and only one enters the other, the average baseline score may differ noticeably.

As the number of randomized units increases, relative imbalances generally become less pronounced under suitable assumptions, although exact balance remains unlikely across every measured characteristic.

The relevant sample size is the number of independently randomized units. In a cluster trial, randomizing 10 schools does not provide the same allocation balance opportunities as independently randomizing hundreds of students.

This distinction is particularly important when interpreting baseline tables from trials with few clusters.

Can Baseline Imbalance Occur Even With Equal Group Sizes?

Yes. Numerical balance and prognostic balance are different properties.

A trial may assign exactly 50 participants to each arm while one group has substantially higher baseline achievement or greater disease severity.

Block randomization can control treatment allocation numbers within completed blocks, but it does not automatically balance participant characteristics.

Stratified randomization may improve balance on selected characteristics, but it cannot guarantee equality across every measured or unmeasured variable.

These phenomena should not be treated as interchangeable. A trial can have equal group sizes but important covariate differences, or unequal group sizes while preserving valid random assignment.

How Large Can a Chance Baseline Difference Be?

The size of a chance difference depends on the variability of the baseline characteristic, the number of randomized units, and the allocation mechanism.

For a continuous baseline variable, a useful illustration comes from the sampling variability of a difference between two independent group means.

This calculation illustrates the scale of random variation rather than providing a test for whether randomization was valid.

It does not imply that every observed difference is harmless or that investigators should ignore evidence of improper allocation.

Why Are Baseline Significance Tests Generally Discouraged?

Researchers sometimes conduct t-tests or chi-square tests on baseline characteristics to determine whether randomization succeeded.

This practice is generally discouraged because, under valid randomization, baseline differences arise from the allocation mechanism rather than from treatment effects.

A statistically significant baseline difference does not establish that randomization was defective. Conversely, a nonsignificant result does not establish that the groups are sufficiently comparable or that allocation concealment was adequate.

When many baseline characteristics are tested, some small p-values may arise by chance.

Moreover, p-values are strongly influenced by sample size. A potentially important prognostic difference may be statistically nonsignificant in a small trial, while a trivial difference may become statistically significant in a large one.

CONSORT reporting guidance discourages routine hypothesis testing of baseline differences in randomized trials. Descriptive reporting and assessment of the randomization process are more informative.

What Should Researchers Examine Instead of Baseline P-Values?

Researchers should examine the magnitude and direction of observed differences, their scientific relevance, and whether the pattern is compatible with the documented allocation procedure.

For continuous characteristics, means, standard deviations, medians, or appropriate distributional summaries may be useful. For categorical variables, counts and percentages provide relevant information.

Standardized differences can help describe imbalance without making the description depend directly on sample size.

However, there is no universal standardized-difference threshold that determines whether a randomized trial is valid.

A baseline characteristic may differ substantially between groups yet have little prognostic importance for the primary outcome. Another characteristic may show a smaller numerical difference but strongly predict that outcome.

The assessment should therefore be substantive rather than based solely on arbitrary numerical cutoffs.

When Might Baseline Imbalance Suggest a Randomization Problem?

Although chance imbalance is expected, certain patterns may warrant investigation.

For example, investigators should examine whether allocation sequences were accessible to recruiters, whether eligibility decisions changed after assignments became known, or whether treatment assignments were implemented out of sequence.

Unexpectedly systematic differences across several important characteristics may raise concerns, particularly when accompanied by evidence of procedural irregularities.

However, baseline characteristics alone rarely establish the cause of a problem. Investigators should inspect allocation records, enrollment timing, eligibility documentation, and audit trails.

The Cochrane RoB 2 framework considers baseline differences alongside sequence generation and allocation concealment when assessing bias arising from the randomization process.

The distinction between allocation concealment and blinding is important here because foreknowledge of upcoming assignments can compromise enrollment even when the sequence itself was randomly generated.

Does Baseline Imbalance Bias the Treatment Effect?

Under properly implemented randomization, a chance baseline difference does not by itself create systematic confounding across the randomization distribution.

Nevertheless, a particular realized imbalance can affect the precision of an estimate and may contribute to a treatment difference that differs from the underlying causal effect in that particular sample.

The consequences depend on the outcome, the prognostic importance of the imbalanced characteristic, and the analysis method.

For example, if baseline achievement strongly predicts final achievement, adjusting for the baseline score may improve precision and account for some chance variation in the observed comparison.

This does not mean that randomization failed. It means that statistical analysis can use prognostic information to estimate the treatment effect more efficiently.

Researchers should distinguish the unbiasedness properties of an estimator under repeated randomization from the accuracy of any single realized estimate.

Should Baseline Covariates Be Adjusted in the Analysis?

Prespecified adjustment for important baseline prognostic variables is often appropriate in randomized trials.

For a continuous outcome, analysis of covariance can compare treatment groups while adjusting for the corresponding baseline measurement.

Such adjustment may improve statistical precision and reduce residual outcome variability.

However, the covariates should ordinarily be selected before examining treatment outcomes, based on scientific relevance and the intended analysis.

Researchers should not decide which variables to adjust for solely because their baseline p-values fall below an arbitrary threshold.

When stratified randomization or minimization was used, the analysis should generally account for the allocation factors as appropriate to the statistical model.

The choice of covariates should also consider whether they were measured before treatment and whether the proposed adjustment is consistent with the target estimand.

Does Stratified Randomization Eliminate Baseline Imbalance?

No. Stratified randomization can improve balance on selected baseline categories, particularly when combined with an appropriate restricted allocation procedure.

It does not guarantee identical values within those categories, nor does it balance every characteristic that was not selected.

For example, stratifying students into lower and higher baseline achievement groups may balance the number assigned from each category, while their actual continuous achievement scores still differ.

Researchers considering when stratified randomization is justified should therefore focus on important prognostic variables rather than attempting to eliminate every possible difference.

Should You Rerandomize if the Groups Look Imbalanced?

Investigators should not discard a valid randomization result simply because the resulting baseline table appears unfavorable.

Repeatedly generating assignments until the groups look sufficiently similar, without a prespecified restricted randomization procedure, changes the allocation mechanism and may undermine the validity of conventional analyses.

There are legitimate rerandomization designs in which acceptable balance criteria and the randomization procedure are specified in advance. These are distinct from ad hoc rerandomization after inspecting an allocation.

The decision about whether rerandomization is appropriate must therefore distinguish a planned design from an improvised response to observed differences.

How Should Baseline Imbalance Be Reported?

Trial reports should provide baseline characteristics by randomized group using appropriate descriptive statistics.

Researchers should explain the randomization method, any stratification or minimization factors, and the covariates included in the prespecified analysis.

Material departures from the allocation protocol should be disclosed, together with any investigation and its implications.

Observed baseline differences should not be concealed merely because they appear unfavorable.

Nor should authors describe a trial as successfully randomized solely because baseline significance tests were nonsignificant.

Transparent reporting allows readers to assess the actual allocation process and interpret the treatment comparison in its proper methodological context.

Baseline Achievement Differences After Valid Randomization

The observed five-point difference does not establish selection bias. It may be a chance consequence of the realized allocation.

However, because baseline achievement is prognostic, the difference is relevant to understanding the outcome comparison and the potential value of covariate adjustment.

If the investigators had discovered that recruiters could predict assignments and altered enrollment accordingly, the interpretation would be different. That would provide direct evidence of a compromised allocation process rather than merely a chance baseline difference.

The appropriate response is therefore to evaluate the procedure and apply the planned analysis, not to demand identical baseline tables as proof of successful randomization.

Common Misconceptions About Baseline Imbalance

What to Do When Randomized Groups Differ at Baseline

Begin by verifying that the allocation sequence was generated and implemented according to the protocol. Review concealment, enrollment timing, eligibility decisions, and assignment records.

If no irregularities are identified, interpret baseline differences as possible consequences of chance rather than automatically treating them as evidence of bias.

Baseline characteristics should inform interpretation, but they should not become a retrospective test of whether the randomized trial deserves to be called randomized.

Preserve the distinction between a chance difference, a prognostically important difference, and evidence of a compromised allocation process.

Before Interpreting Baseline Differences in an RCT

Questions About Baseline Imbalance After Randomization

Chance Imbalance Is Compatible With Valid Randomization

How to Cite This Guide

This guide is intended to be read, shared, and used in research, teaching, and academic work. If you draw on its ideas, explanations, or other content, please acknowledge the source by citing the guide. Doing so gives appropriate credit and helps your readers locate the original resource.